Cypherpunk Technologies increased its Zcash treasury to 314,185.70 ZEC and invested $5 million in Zcash Open Development Labs to support privacy tech. Its subsidiary Leap Therapeutics received FDA Fast Track for sirexatamab in colorectal cancer and presented positive clinical data. The company reported a $77.2 million net loss in Q1 2026, mainly due to unrealized losses from Zcash price declines. Cypherpunk continues to focus on privacy technology and digital asset growth amid market volatility.
On December 1, 2025, YieldMax Ultra Option Income Strategy ETF (ULTY) executed a 1-for-10 reverse split, raising its share price tenfold but not increasing investor value. The fund charges a high 1.24% expense ratio, significantly more than comparabl...
YieldMax COIN Option Income Strategy ETF (CONY) promises a 78% yield by using a synthetic covered call strategy on Coinbase shares, but investors have faced a 56.25% loss over the past year, nearly matching Coinbase’s 59.10% drop. The fund caps upsid...
US stock markets are trading sideways as geopolitical tensions in the Middle East weigh on investor sentiment. The Dow Jones 30 found support at the critical 52,000 level and remains in an overall uptrend, suggesting buying opportunities despite shor...
Coinsilium Group Limited will invest an additional $200,000 in Predictive Labs, increasing its total commitment to $350,000 and acquiring nearly 12% ownership. This follows Predictive Labs' launch of Nijinn, a platform aggregating data from predictio...
Coinbase Global is transforming from a simple Bitcoin price proxy to a diversified crypto business. Stablecoin-related revenues and subscription services now make up 44% of its net revenue and have grown despite overall crypto market declines. Additi...
